Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Craig Fraser | President and CEO | 2023-09-27 | 2,500 | $1.02 | $2.55kBuy |
Craig Fraser | President and CEO | 2023-09-26 | 2,500 | $0.90 | $2.25kBuy |
Craig Fraser | President and CEO | 2023-04-26 | 1,497 | $1.77 | $2.65kBuy |
Craig Fraser | President and CEO | 2023-04-25 | 1,315 | $1.89 | $2.49kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Lph Investments Ltd | 898.02% | 46,232,085 | $17.01M | Insider |
Lees Pharmaceutical Holdings Ltd | 337.41% | 17,370,770 | $6.39M | Insider |
China Cardiovascular Focus Ltd | 156.63% | 8,063,861 | $2.97M | Insider |
James Huang | 119.51% | 6,152,576 | $2.26M | Insider |
Panacea Venture Healthcare Fund I LP | 87.94% | 4,527,345 | $1.67M | Insider |
Ivy Blue Holdings Ltd | 84.24% | 4,336,790 | $1.60M | Insider |
Lph Ii Investments Ltd | 77.86% | 4,008,234 | $1.48M | Insider |
Center Laboratories Inc | 48.14% | 2,478,176 | $911.97k | Insider |
Robert J. Capetola | 8.48% | 436,417 | $160.60k | Insider |
Christopher J. Schaber | 4.52% | 232,771 | $85.66k | Insider |